Our patents represent Claret Medical’s commitment to developing unique and original products designed to help protect patients from potential strokes during Transcatheter Aortic Valve Replacement (TAVR) procedures.
The Sentinel™ Cerebral Protection Systemis covered by one or more of U.S. Patent Nos. 8,382,788; 9,017,364; 9,326,843; 9,345,565; 9,492,264; and 9,636,205 and European Patent Nos. 2387427 and 2480165.
Method of use covered by one or more of U.S. Patent Nos. 8,206,412; 8,372,108; 8,876,796 and 9,055,997.
Other U.S. and Foreign patents pending.